PubRank

Comparison of human papillomavirus testing strategies for triage of women referred with low-grade cytological abnormalities.

PubWeight™: 0.87‹?›

🔗 View Article (PMID 23452990)

Published in Eur J Cancer on February 26, 2013

Authors

David Mesher1, Anne Szarewski1, Louise Cadman1, Janet Austin1, Lesley Ashdown-Barr1, Linda Ho1, George Terry1, Martin Young2, Mark Stoler3, Christine Bergeron4, Julie McCarthy5, Corrina Wright5, Stuart Liddle6, W P Soutter7, Deirdre Lyons8, Jack Cuzick9

Author Affiliations

1: Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary, University of London, Charterhouse Square, London EC1M 6BQ, UK.
2: Cytopathology Department, Royal Free Hospital, London NW3, UK.
3: Department of Pathology, University of Virginia Health System, Virginia 22908, USA.
4: Laboratoire Pasteur-Cerba, 95066 Cergy Pontoise Cedex 9, France.
5: Cytopathology Department, St. Mary's Hospital, Praed Street, London W2 1PG, UK.
6: The Doctors Laboratory, 60 Whitfield Street, London W1T 4EU, UK.
7: Department of Gynaecology, Hammersmith and Queen Charlotte's & Chelsea Hospitals, Du Cane Rd., London W12 0HS, UK.
8: Department of Gynaecology, St. Mary's Hospital, Praed Street, London W2 1PG, UK.
9: Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary, University of London, Charterhouse Square, London EC1M 6BQ, UK. Electronic address: j.cuzick@qmul.ac.uk.

Articles citing this ↘

Epidemiology of ocular surface squamous neoplasia in Africa. Trop Med Int Health (2013) 1.50

Disagreement between human papillomavirus assays: an unexpected challenge for the choice of an assay in primary cervical screening. PLoS One (2014) 1.11

The Aptima HPV assay fulfills the cross-sectional clinical and reproducibility criteria of international guidelines for human papillomavirus test requirements for cervical screening. J Clin Microbiol (2013) 0.85

Triaging borderline/mild dyskaryotic Pap cytology with p16/Ki-67 dual-stained cytology testing: cross-sectional and longitudinal outcome study. Br J Cancer (2014) 0.85

The BD Onclarity HPV Assay on Samples Collected in SurePath Medium Meets the International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening. J Clin Microbiol (2016) 0.82

Triage of HR-HPV positive women with minor cytological abnormalities: a comparison of mRNA testing, HPV DNA testing, and repeat cytology using a 4-year follow-up of a population-based study. PLoS One (2014) 0.82